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Introduction
 Sulfamethoxazole is a broad spectrum antibiotic, which is effective against both 
the Gram positive and Gram negative bacteria such as Listeria monocytogenes and E. coli 
and is used to treat the bacterial infections such as bronchitis, urinary tract infections, and 
prostatitis etc[1]. It is bacteriostatic in nature and acts by preventing the folic acid synthesis 
in some bacteria[2,3]. The combination of sulfamethoxazole and trimethoprim is used to 
treat various microbial infections such as bronchitis, urinary tract infections, traveller’s di-
arrhoea, middle ear infections (otitis media), and bacillary dysentery (shigellosis)[4]. Apart 
from that, this combination is also used in the treatment of infections caused by streptococ-
ci, Toxoplasma gondii, Pneumocystis jiroveci, Nocardia, Salmonella, methicillin-resistant 
Staphylococcus aureus[5], Mycobacterium tuberculosis[6], Stenotrophomonas maltophila[7], 
etc.
 Although, sulfamethoxazole is well absorbed orally; however, the bioavailability 
of any drug is affected by its stability and analytical profile[8]. The physicochemical prop-
erties of pharmaceutical compounds play a vital role in its solubility, dissolution, stability, 
and bioavailability profile. Hence, several techniques are used by researchers in order to 
improve the biological activities of drug molecules through altering its physiochemical 
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Abstract
  Sulfamethoxazole is an antibiotic, which inhibits the bacteria by interfering in its folic acid synthesis mechanism. 
The objective of this study was to analyze the Trivedi Effect®-Consciousness Energy Healing Treatment on the phys-
icochemical and thermal properties of sulfamethoxazole by using modern analytical techniques. The sulfamethoxaz-
ole sample was classified as control and treated samples. The control sample did not receive the Biofield Treatment, 
while the treated sample received the Biofield Treatment remotely by a renowned Biofield Energy Healer, Dahryn 
Trivedi. The particle sizes of the treated sample were significantly reduced by 7.99% (d10), 3.05% (d50), 3.80% (d90), 
and 3.03%{D(4,3)}; whereas, the specific surface area of the particles was increased by 5.19% in the treated sample 
compared to the control sample. The PXRD peak intensities and crystallite sizes were altered ranging from -70.86% to 
52.36% and -6.01% to 75.34%, respectively; whereas the average crystallite size was significantly increased by 27.28% 
in the treated sulfamethoxazole compared with the control sample. The sample residual amount and maximum thermal 
degradation temperature were increased by 2.13% and 4.21%, respectively, in the treated sample compared to the con-
trol sample. The decomposition temperature and latent heat of decomposition were increased by 3.26% and 19.36%, 
respectively, in the treated sample compared to the untreated sample. The Biofield Treated sulfamethoxazole might con-
vert to a novel polymorph of the drug, with reduced particle size, increased surface area, and improved thermal stability. 
This can be helpful in improving the solubility, bioavailability, and stability of the sulfamethoxazole and would be more 
efficacious for the treatment of infections in the ear, urinary tract infections, traveler’s diarrhoea, bronchitis, shigellosis, 
and pneumonia, etc.
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properties such as such as crystalline structure, particle size, sur-
face area, thermal stability, etc[9,10].
 The Consciousness Energy Healing Treatment has been 
reported in various scientific studies due to its ability to alter the 
physical, structural, and thermal properties of the pharmaceuti-
cal and nutraceutical compounds[11,12]. Energy therapies are also 
used in the integrated healthcare approach along with the Com-
plementary and Alternative Medicine (CAM) therapies for the 
treatment of various health conditions[13,14]. Various alternative 
healing therapies such as yoga, meditation, homeopathy, acu-
pressure, acupuncture, hypnotherapy, healing touch, relaxation 
techniques, Pilates, Reiki, Ayurvedic medicine, traditional Chi-
nese herbs and medicines, cranial sacral therapy, etc. are recom-
mended by the National Institutes of Health (NIH) to include 
under the CAM category and such therapies are also accepted 
by huge population due to their advantages[15,16]. In a similar 
way, the Biofield Energy Healing (the Trivedi Effect®) also be-
come popular worldwide because of its significant impact on the 
non-living materials as well as the living organisms. The Trive-
di Effect®-Consciousness Energy Healing Treatment has been 
reported for its significant impact on the properties of crops[17], 
metals, ceramics, and polymers[18], altered characteristics in mi-
crobes[19], plants[20], livestock[21], and skin health[22]. Thus, this 
study was aimed to determine the effect of the Biofield Ener-
gy Treatment (the Trivedi Effect®) on the physicochemical and 
thermal properties of sulfamethoxazole by using various ana-
lytical techniques such as, particle size analysis (PSA), powder 
X-ray diffraction (PXRD), Thermogravimetric analysis (TGA), 
and differential scanning calorimetry (DSC).
Materials and Methods 
Chemicals and Reagents
 The sulfamethoxazole sample was purchased from Sig-
ma Aldrich, USA. All other chemicals used during the experi-
ments were of analytical grade available in India. 
Consciousness Energy Healing Treatment Strategies
 The sulfamethoxazole sample was divided into two 
equal parts. One part of sulfamethoxazole did not receive the 
Biofield Energy Treatment and the sample was considered as a 
control sample. Further, the control sample was treated with a 
“sham” healer for comparison purpose. The “sham” healer did 
not have any knowledge about the Biofield Energy Treatment. 
However, the second part of sulfamethoxazole was treated with 
the Biofield Energy Treatment remotely under standard labora-
tory conditions for 3 minutes and known as a treated sample. 
This Biofield Energy Treatment was provided through the heal-
er’s unique energy transmission process by the renowned Biof-
ield Energy Healer, Dahryn Trivedi, USA, to one part of the test 
sample. After the treatment both the samples were kept in the 
sealed conditions and characterized using PSA, PXRD, TGA/
DTG, and DSC analytical techniques. 
Characterization
Particle Size Analysis (PSA)
 The particle size analysis of sulfamethoxazole sam-
ples was conducted on Malvern Mastersizer 2000, of the UK 
with a detection range between 0.01 µm to 3000 µm using wet 
method[23,24]. The sample unit (Hydro MV) was filled with a dis-
persant medium (sunflower oil) and the stirrer operated at 2500 
rpm. The PSA analysis of sulfamethoxazole was performed to 
obtain the average particle size distribution. Where, d(0.1) μm, 
d(0.5) μm, d(0.9) μm represent particle diameter corresponding 
to 10%, 50%, and 90% of the cumulative distribution. D(4,3) 
represents the average mass-volume diameter, and SSA is the 
specific surface area (m2/g). The calculations were done by using 
software Mastersizer Ver. 5.54.
 The percent change in particle size (d) at below 10% 
level (d10), 50% level (d50), 90% level (d90), and D(4,3) was cal-
culated using the following equation 1:
Where d
Control
 and dTreated are the particle size (μm) for at below 
10% level (d10), 50% level (d50), and 90% level (d90) of the con-
trol and the Biofield Energy Treated sulfamethoxazole samples, 
respectively.
The percent change in surface area (S) was calculated using the 
following equation 2:
Where S
Control
 and STreated are the surface area of the control and 
the Biofield Energy Treated sulfamethoxazole samples, respec-
tively.
Powder X-ray Diffraction (PXRD) Analysis
 The PXRD analysis of control and the Biofield Energy 
Treated sulfamethoxazole was performed with the help of Riga-
ku MiniFlex-II Desktop X-ray diffractometer (Japan)[25,26]. The 
Cu Kα radiation source tube output voltage used was 30 kV and 
tube output current were 15 mA. Scans were performed at room 
temperature. The average size of individual crystallites was cal-
culated from XRD data using the Scherrer’s formula (3):
G = kλ/βcosθ                                                        (3)
Where k is the equipment constant (0.94), G is the crystallite 
size in nm, λ is the radiation wavelength (0.154056 nm for Kα1 
emission), β is the full-width at half maximum (FWHM), and θ 
is the Bragg angle[27].
The % change in crystallite size (G) of sulfamethoxazole was 
calculated using the following equation 4:
Where G
Control
 and GTreated are the crystallite size of the control 
and the Biofield Energy Treated samples, respectively.
Thermal Gravimetric Analysis (TGA)/ Differential Thermo-
gravimetric analysis (DTG)
 TGA/DTG thermograms of the control and the Biofield 
Energy Treated sulfamethoxazole were obtained with the help of 
TGA Q50TA instruments. A sample of 4 - 15 mg was loaded to 
the platinum crucible at a heating rate of 10ºC/min from 25°C to 
1000°C with the recent literature[23,24]. The % change in weight 
loss (W) was calculated using the following equation 5:
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WhereW
Control
 and WTreated are the weight loss of the control and 
the Biofield Energy Treated sulfamethoxazole, respectively.
The % change in maximum thermal degradation temperature 
(T
max
) (M) was calculated using the following equation 6:
Where M
Control
 and MTreated are the Tmax values of the control and 
the Biofield Energy Treated sulfamethoxazole, respectively.
Differential Scanning Calorimetry (DSC)
 The DSC analysis of sulfamethoxazole was performed 
with the help of DSC Q200, TA instruments. A sample of ~1-5 
mg was loaded into the aluminium sample pan at a heating rate 
of 10ºC/min from 30°C to 350°C[23,24]. The percent change in 
melting point (T) was calculated using the following equation 7:
Where T
Control
 and TTreated are the melting point of the control and 
the treated samples, respectively.
The % change in the latent heat of fusion (ΔH) was calculated 
using the following equation 8:
 
Where ΔH
Control 
and ΔHTreated are the latent heat of fusion of the 
control and the treated sulfamethoxazole, respectively.
Results and Discussion
Particle Size Analysis (PSA)
 The particle size analysis corresponding to 10%, 50%, 
and 90% of the cumulative distribution and average mass-vol-
ume diameter of the control and the Biofield Energy Treated 
sulfamethoxazole samples were done and the results are given 
in Table 1. The particle size distribution of the control sulfame-
thoxazole sample at d10, d50, d90, and D(4, 3) was observed as 
14.76 μm, 45.85 μm, 102.39 μm, and 53.23 μm, respectively. 
However, the particle size distribution of the Biofield Energy 
Treated sample was found to be decreased by 7.99%, 3.05%, 
3.80%, and 3.93% at d10, d50, d90, and D(4, 3), respectively, com-
pared to the control sample (Table 1). 
 The specific surface area of the Biofield Energy Treated 
sulfamethoxazole was observed as 0.324 m2/g, which was in-
creased by 5.19% as compared to the SSA of the control sample 
(0.308 m2/g). The resultant increase in the surface area of the 
treated sample might occur due to the significant reduction in the 
particle size as compared to the control sample. It is presumed 
here that the Trivedi Effect® might behave as an external force 
that reduces the particle sizes of the sulfamethoxazole sample. 
The particle size distribution of drug has a significant impact 
on the solubility, absorption, bioavailability, and complete drug 
performance in the body[28,29]. Also, the reduction in particle size 
increases the surface area of the compound, which is used as 
a technique to enhance the solubility and bioavailability of the 
drug[30]. Hence, the particle size analysis of the treated sulfame-
thoxazole indicated the possible improvement in its bioavailabil-
ity profile after the Biofield Energy Treatment as compared to 
the untreated sample.
Table 1: Particle size distribution of the control and the Biofield Energy 
Treated sulfamethoxazole.
Parameter d10(µm) d50(µm) d90(µm)
D(4,3)
(µm)
SSA
(m2/g)
Control 14.76 45.85 102.39 53.23 0.308
Biofield 
Treated
13.58 44.45 98.50 51.14 0.324
Percent 
change*(%) -7.99 -3.05 -3.80 -3.93 5.19
d10, d50, and d90: particle diameter corresponding to 10%, 50%, 
and 90% of the cumulative distribution, D(4,3): the average 
mass-volume diameter, and SSA: the specific surface area. *de-
notes the percentage change in the Particle size distribution of 
the Biofield Energy Treated sample with respect to the control 
sample.
Powder X-ray Diffraction (PXRD) Analysis 
 The PXRD diffractograms of the control and Biofield 
Energy Treated sulfamethoxazole samples are shown in Figure 
1. The presence of sharp and intense peaks in the diffractograms 
of both the samples revealed their crystalline nature. The data 
regarding the Bragg’s angle, relative intensities, and crystallite 
sizes for both the samples are given in Table 2 along with their 
further analysis. 
 
Figure 1: PXRD diffractograms of the control and Biofield Energy 
Treated sulfamethoxazole.
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 The data showed that the highest peak intensity (100%) 
in the diffractogram of the control sample was observed at 2θ 
equal to 23.87°, while it was observed at 2θ equal to 20.93° in 
the Biofield Energy Treated sample. The significant alterations 
were also found in the Bragg’s angle of the other characteris-
tic peaks of the Biofield Energy Treated sample as compared 
to the control sulfamethoxazole sample. The peak intensities of 
the characteristic peaks of the Biofield Energy Treated sample 
were observed to be altered ranging from -70.86% to 52.36%, 
as compared to the control sample, which might indicate the 
possible changes in the crystallinity of the treated sulfamethox-
azole sample in comparison to the untreated one. Similarly, the 
crystallite sizes corresponding to most of the characteristic dif-
fraction peaks of the Biofield Energy Treated sample were sig-
nificantly altered ranging from -6.01% to 75.34% as compared 
to the control sample. Also, the alterations were observed in the 
average crystallite size of the Biofield Energy Treated sample 
(375.57 nm), which was significantly increased by 27.28% as 
compared to the control sample (295.07 nm). Hence, the overall 
PXRD data indicated the alterations in the crystallinity and the 
crystallite size of the treated sulfamethoxazole sample after the 
Biofield Energy Treatment, as compared to the control sample. 
Table 2: PXRD data for the control and Biofield Energy Treated sulfamethoxazole.
Entry No.
Bragg angle (°2θ) Intensity (cps) Crystallite size (G, nm)
Control Treated Control Treated % Changea Control Treated % Changeb
1 12.31 12.50 249 276 10.84 296 519 75.34
2 13.71 13.97 82 119 45.12 270 338 25.19
3 17.47 17.68 352 263 -25.28 273 336 23.08
4 18.54 18.76 122 171 40.16 332 419 26.20
5 19.63 19.77 128 130 1.56 339 539 59.00
6 20.74 20.93 615 937 52.36 313 405 29.39
7 21.56 21.78 332 318 -4.22 353 416 17.85
8 22.39 22.59 162 222 37.04 320 393 22.81
9 23.87 24.10 927 715 -22.87 283 266 -6.01
10 24.69 24.93 146 133 -8.90 240 243 1.25
11 27.40 27.62 284 304 7.04 322 378 17.39
12 28.75 29.01 439 192 -56.26 313 396 26.52
13 32.16 32.40 381 210 -44.88 235 298 26.81
14 34.97 35.19 175 51 -70.86 242 312 28.93
*denotes the percentage change in the crystallite size of Biofield Energy Treated sample with respect to the control sample.
 Some studies reported that the Biofield Energy Treat-
ment might produce a new polymorph of the compound by 
changing the peak intensities and crystallite sizes and thereby 
affecting the morphology and crystalline structure of the com-
pound[31,32]. Thus, the significant changes taking place in the 
peak intensities and crystallite size of the treated sample might 
be resulted due to the formation of a new polymorph of the sulfa-
methoxazole sample after the Biofield Energy Treatment, which 
might improve the drug profile of sulfamethoxazole compared to 
the untreated sample. 
Thermal Gravimetric Analysis (TGA)/ Differential Thermo-
gravimetric Analysis (DTG)
 The TGA/DTG technique was used to analyse the im-
pact of the Biofield Energy Treatment on the thermal stability 
profile of the treated sulfamethoxazole sample in comparison to 
the untreated sample. The TGA data for both the samples (Figure 
2) revealed that there was a slight reduction (1.04%) in the total 
weight loss of the Biofield Energy Treated sample during the 
sample degradation as compared to the control sample. Hence, 
the residue amount of the Biofield Energy Treated sulfamethox-
azole sample was increased by 2.13% (Table 3) in comparison to 
the control sample. Thus, it indicated the improved thermal sta-
bility of the treated sulfamethoxazole sample after the Biofield 
Energy Treatment, as compared to the untreated sample.
 
Figure 2: TGA thermograms of the control and Biofield Energy Treated 
sulfamethoxazole.
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Table 3: TGA/DTG data of the control and Biofield Energy Treated 
samples of sulfamethoxazole.
Sample
TGA DTG
Total weight 
loss (%)
Residue % T
max
 (°C)
Control 67.21 32.79 242.83
Biofield Energy 
Treated
66.51 33.49 253.06
% Change* -1.04 2.13 4.21
*denotes the percentage change of the Biofield Energy Treated 
sample with respect to the control sample,
T
max
 = the temperature at which maximum weight loss takes 
place in TG or peak temperature in DTG.
 
Figure 3: DTG thermograms of the control and Biofield Energy Treated 
sulfamethoxazole.
 The DTG thermograms (Figure 3) of both the samples 
showed single peak, and their results revealed the significant 
improvement (4.21%) in the maximum degradation tempera-
ture (T
max
) of the Biofield Energy Treated sample (253.06°C), 
as compared to the T
max 
of the control sample (242.83°C). Over-
all, the TGA/DTG studies showed that the thermal stability of 
the Biofield Energy Treated sample was improved, which might 
occur due to the possible alteration in the crystalline structure 
of the treated sulfamethoxazole, as compared with the untreated 
sample.
Differential Scanning Calorimetry (DSC) Analysis
 DSC analysis is used as a technique for determining 
the thermodynamic changes that will occur during the heating of 
drug. Such changes might involve melting, recrystallization, and 
de-solvation, etc. that represent themselves in the form of the 
endothermic or exothermic peaks on the DSC thermograms[33]. 
The studies reported the presence of two peaks in the DSC curve 
of sulfamethoxazole. The first peak reported was an endother-
mic peak that is present ~172 °C and denotes the fusion process; 
while the second peak was exothermic in nature (exist ~270 °C) 
and showed the oxidation of evolved products as a result of the 
thermal decomposition of the sample[34]. The DSC thermograms 
of both the samples (Figure 4) were observed similarly as report-
ed in the literature. The first endothermic peak, i.e., the melting/
fusion peak was observed at a similar temperature in the thermo-
grams of both the samples. The results showed a slight increase 
(0.28%) in the melting point and slight reduction in the latent 
heat of fusion (ΔH
fusion
) (0.38%) of the Biofield Energy Treated 
sample, compared to the control sulfamethoxazole sample (Ta-
ble 4).
 
Figure 4: DSC thermograms of the control and Biofield Energy Treated 
sulfamethoxazole.
Table 4: Comparison of DSC data between the control and Biofield 
Energy Treated sulfamethoxazole.
Peak Description Melting Point (°C) ΔH
fusion
(J/g)
Peak 1
Control sample 169.70 129.70
Biofield Treated 
sample 170.17 129.20
% Change* 0.28 -0.38
Peak 2
Control sample 271.94 590.90
Biofield Treated 
sample 280.82 705.30
% Change* 3.26 19.36
ΔH: Latent heat of fusion; *denotes the percentage change of 
the Biofield Energy Treated sample with respect to the control 
sample.
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 The thermograms of the control and the treated sam-
ple also possess a broad exothermic inflection, which is resulted 
due to oxidation of evolved products and thermal decomposition 
of the samples. The results showed that the temperature corre-
sponding to this peak of the Biofield Energy Treated sample was 
increased by 3.26% along with 19.36% increase in the ∆H, as 
compared to the control sample. Thus, the DSC data indicated 
the improved thermal stability of the treated sulfamethoxazole 
sample after the Biofield energy Treatment as compared to the 
untreated sample. It is presumed that the Biofield Energy treat-
ment might cause some alterations in the molecular chains and 
crystallization structure of the sulfamethoxazole sample, which 
might be responsible for the improved thermal stability profile 
of the treated sulfamethoxazole sample[35].
Conclusion
 The Trivedi Effect®-Consciousness Energy Healing 
Treatment has shown a significant impact on the physicochem-
ical and thermal properties of sulfamethoxazole drug. The Bio-
field Energy Treated sample showed a significant reduction in 
the particle size by 7.99, 3.05%, 3.80%, and 3.93% at d10, d50, 
d90, and D(4,3), respectively, compared to the untreated sample. 
Thus, the specific surface area of the Biofield Energy Treated 
sulfamethoxazole was increased by 5.19% compared with the 
control sample. Such changes might increase the solubility, dis-
solution, and absorption parameters and thereby increase the 
bioavailability of the treated sulfamethoxazole as compared to 
the untreated sample. The PXRD peak intensities and the crys-
tallite sizes of the Biofield Energy Treated sample were signifi-
cantly altered ranging from -70.86% to 52.36% and -6.01% to 
75.34%, respectively, compared to the untreated sample. The 
average crystallite size of the Biofield Energy Treated sample 
was significantly increased by 27.28% as compared to the con-
trol sample. The Biofield Energy Treated sample also showed 
a 4.21% significant increase in the T
max
 as compared with the 
control sample. The decomposition temperature and ΔH
decom-
position
 of the Biofield Energy Treated sample were significantly 
increased by 3.26% and 19.36%, respectively, as compared to 
the control sample. Thus, the thermal studies of the Biofield 
Energy Treated sulfamethoxazole indicated its improved ther-
mal stability in comparison to the untreated sample. The overall 
study concluded that the Trivedi Effect®-Consciousness Energy 
Healing Treatment might create a new polymorphic form of the 
drug with altered crystallinity that might possess better solubili-
ty, dissolution, bioavailability, and improved thermal stability as 
compared with the untreated sample. Hence, the Biofield Energy 
Treated sulfamethoxazole may have better efficacy for the pre-
vention and treatment of various bacterial diseases such as ear 
infections, urinary tract infections, traveler’s diarrhea, bronchi-
tis, shigellosis, and Pneumocystis jiroveci pneumonia, etc.
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